SEC Form 4 · accession 0001140361-18-009846
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Thomas B Neff
Officer — Chief Executive Officer · Director
Period of report
Dec 19, 2016
Accepted (ET)
Feb 23, 2018 · 4:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 19, 2016 | M | 24,844 | $4.025 | A | 2,945,349 | D |
Table II — derivative securities
No Table II lines on this filing.